Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06490367 · ClinicalTrials.gov registry record · NA

Time-Restricted Eating in Huntington's Disease: A Clinical Pilot Study

A NA study of Huntington Disease, sponsored by Oregon Health and Science University.

Completed
Registry status
NA
Development phase
22
Enrollment target
1
Study location

NCT06490367 is a NA study of Huntington Disease that has completed, run by Oregon Health and Science University. The registered enrollment target is 22 participants, below the 635-participant average among 35 other Huntington Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06490367, a NA study of Huntington Disease, has completed, sponsored by Oregon Health and Science University.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

This trial examines whether 12 weeks of time-restricted eating (TRE), otherwise known as intermittent fasting, appears safe and feasible in persons with early-stage Huntington's disease (HD). The study also explores the effects of TRE on biomarkers and clinical measures associated with HD progression.

Conditions Studied

Interventions

  • BEHAVIORAL Time-Restricted Eating Diet

Study Locations (1)

Oregon

  • Oregon Health and Science University - Portland

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2024-08-29
Est. Completion 2025-05-30
Phase NA

What the Registry Record Tells You About NCT06490367

The ClinicalTrials.gov registry entry for NCT06490367 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 635-participant average among 35 other Huntington Disease trials with a reported enrollment target (97% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Huntington Disease appearing as the primary indexed condition, and to 1 intervention - of which Time-Restricted Eating Diet is the first listed.

NCT06490367 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT06490367 about?

NCT06490367 is a clinical study titled "Time-Restricted Eating in Huntington's Disease: A Clinical Pilot Study". This trial examines whether 12 weeks of time-restricted eating (TRE), otherwise known as intermittent fasting, appears safe and feasible in persons with early-stage Huntington's disease (HD). The study also explores the effects of TRE on biomarkers and clinical measures associated with HD progressio...

What is the current status of trial NCT06490367?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2024-08-29. Estimated completion is 2025-05-30.

What conditions does trial NCT06490367 study?

This clinical trial studies the following conditions: Huntington Disease.

What interventions are being tested in trial NCT06490367?

The interventions under investigation include: Time-Restricted Eating Diet (BEHAVIORAL).

Who is sponsoring clinical trial NCT06490367?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06490367 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Huntington Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.